Samantha Johnston

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Samantha C. Johnston, BSc, MIPH, MHEcon, PhD, is a Review Officer at New South Wales Ombudsman office in Sydney, Australia.[1] Prior she was an ME/CFS researcher for Griffith University, School of Medical Science, Gold Coast, Australia.[2]


Notable studies[edit | edit source]

  • 2014, The role of clinical guidelines for chronic fatigue syndrome/myalgic encephalomyelitis in research settings[4] - (Abstract)
  • 2014, The Role of Adaptive and Innate Immune Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[5] - (Full Text)
  • 2017, Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review[6] - (Full Text)
  • 2017, Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients[7] - (Full Text)
  • 2018, Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation[8] - (Abstract)
  • 2020, Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study[9] - (Full text)

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

  • PubMed
  • Twitter
  • Facebook
  • Website
  • YouTube
  • Address: clinic/lab-address-goes-here

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. https://www.linkedin.com/in/samantha-johnston-719a44129/?originalSubdomain=au
  2. https://www.researchgate.net/profile/Samantha_Johnston2
  3. Huth, Teilah K.; Brenu, Ekua; Nguyen, Thao; Hardcastle, Sharni L.; Johnston, Samantha; Ramos, Sandra; Staines, Donald R.; Marshall-Gradisnik, Sonya M. (2014), "Characterization of Natural Killer Cell Phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Journal of Clinical & Cellular Immunology, 5 (3), doi:10.4172/2155-9899.1000223
  4. Johnston, S.C.; Brenu, E.W.; Staines, D.R.; Marshall-Gradisnik, S.M. (January 2, 2014). "The role of clinical guidelines for chronic fatigue syndrome/myalgic encephalomyelitis in research settings". Fatigue: Biomedicine, Health & Behavior. 2 (1): 28–39. doi:10.1080/21641846.2013.860779. ISSN 2164-1846.
  5. Brenu, EW; Huth, TK; Hardcastle, SL; Fuller, K; Kaur, M; Johnston, S; Ramos, S; Staines, D; Marshall-Gradisnik, S (2014), "The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis", International Immunology, 26 (4): 233-42, doi:10.1093/intimm/dxt068, PMID 24343819
  6. Campagnolo, N.; Johnston, S.; Collatz, A.; Staines, D.; Marshall-Gradisnik, S. (January 22, 2017). "Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review". Journal of Human Nutrition and Dietetics. 30 (3): 247–259. doi:10.1111/jhn.12435. ISSN 0952-3871. PMID 28111818.
  7. Nguyen, T.; Johnston, S.; Chacko, A.; Gibson, D.; Cepon, J.; Smith, D.; Staines, D.; Marshall-Gradisnik, S. (2017), "Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients", Asian Pac J Allergy Immunol, 35 (2): 75-81, doi:10.12932/AP0771
  8. Nguyen, T.; Staines, D.; Johnston, S.; Marshall-Gradisnik, S. (July 2018), "Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation", Asian Pac J Allergy Immunol, doi:10.12932/AP-011117-0188
  9. Eaton-Fitch, N.; Johnston, S.C.; Zalewski, P.; Staines, D.; Marshall-Gradisnik, S. (January 22, 2020). "Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study". Quality of Life Research. doi:10.1007/s11136-019-02411-6. ISSN 0962-9343.